The micro-algae extract used in ImmunXT was discovered by scientists at The National Center for Natural Products Research (NCNPR). LifeQuest World Corporation is proud of its association with the NCNPR and other related organizations. The NCNPR was created to bring together an alliance of academia, government, pharmaceutical and other industries to research and develop potentially useful natural products. It is the nation’s only university-affiliated research center devoted to improving human health through multidisciplinary research in the discovery and development of natural, novel bioactive products for use as pharmaceuticals, dietary supplements and to understand the biological and chemical properties of medicinal plants. The NCNPR is one of the country's leading botanical research organizations and has substantial expertise with their discoveries, products, and technologies so that important discoveries can positively impact society.

The NCNPR has a strong foundation and history of excellence in natural products research within the Research Institute of Pharmaceutical Sciences in the School of Pharmacy at the University of Mississippi. The NCNPR programs involve collaborations with the faculty of the Departments of Pharmacognosy, Medicinal Chemistry, Pharmacology, Pharmaceutics, Pharmacy Administration and Pharmacy Practice. In addition, NCNPR scientists work closely with scientists from the Natural Products Utilization Research Unit of the USDA that is housed in the same facility as the NCNPR.

The NCNPR is also a research collaborator with the American Herbal Pharmacopoeia (AHP) to develop quality standards for botanical dietary supplements. These two organizations have combined their efforts in developing the benchmarks for the identity, purity and quality of botanicals. All of the efforts between the NCNPR and AHP provide researchers and industry the tools they need to ensure the identity and quality of botanical dietary supplements. Due to the NCNPR's excellence in botanical research NCNPR scientists receive funding from several government agencies including the U.S. Food and Drug Administration (FDA), the U.S. Army, the National Institute of Health, and the U.S. Department of Agriculture (USDA).

The NCNPR has state-of-the-art research facilities that include the following:

• Specialized natural products isolation and purification laboratories
• Screening laboratories for determining biological activity of natural products
• Natural products analytical laboratories utilizing a broad spectrum of analytical techniques, including gas and liquid chromatography, densitometry, and capillary electrophoresis
• Molecular modeling laboratory where sophisticated computer-based techniques reveal molecular structure properties of drugs and their targets, leading to new drug design
• Production greenhouses, demonstration garden beds, shade houses, and field plots

The scientists at the NCNPR spent approximately ten years in the research and development of the micro-algae extract now known as ImmunXT. Dr David Pasco, Research Professor with the Research Institute of Pharmaceutical Sciences, University of Mississippi, stated that “Our research has shown that this extract is the most powerful, natural immune-stimulatory dietary supplement discovered to date with respect to macrophage activation”. Macrophage activation within the innate immune system is becoming one of the more important aspects of research study concerning the function of the entire immune system.

Validating effectiveness via ongoing trials is just one more way LifeQuest World Corporation demonstrates our commitment to raising the bar in the delivery of safe, effective solutions for consumers.

Published Studies:

• Published scientific article in Planta Medica (2001, vol. 67, pp. 737-742) by researchers at the University of Mississippi – includes the first research on the identification of active extracts from microalgae using a bioassay.
• Published scientific article in The Journal of Alternative and Complementary Medicine (2006, vol. 12, pp. 429-435) by researchers at Johns Hopkins University and the University of Mississippi - showing that ImmunXT activates chemokine expression in human monocytic THP-1 cells.
• Published scientific article in International Immunopharmacology (2006, vol. 6, pp. 1808-1814) by researchers at the University of Mississippi - further research results from the inventors showing that ImmunXT enhances components within both the mucosal and systemic immune systems.
• Published scientific article in the Journal of Medicinal Food (2008, vol 11, pp. 313-322) by researchers in Denmark – clinical study showing enhancement of adaptive immune responses in human subjects by consumption of ImmunXT.

While natural products companies are not required to complete trials, LifeQuest World Corporation has completed the following clinical and research tests on the extract.

Clinical Studies, Case Studies and Other Research:

• 200 completed case studies of varying illnesses and diseases, Denmark/USA
• Safety study, Denmark
• Clinical Study - General Infection study, Denmark
• Clinical Study - Enhancement of the immune system, Denmark
• Clinical Study – Effect of ImmunXT on chronic pain in joints and muscles, Denmark.
• Clinical Study – Herpes Simplex I, Human volunteers, Denmark.
• Clinical Study – Pilot study on the effects of ImmunXT on Natural Killer cell activity and phagocytosis, USA
• Animal Study – Bird-Flu like virus study conducted by Science, Toxicology & Technology Laboratories, a Division of AtoxResearch, USA.
  The extract has a strong scientific pedigree, resulting in a patent issued April 17, 2007. United States Patent #US 7,205,284 B2 ‘Potent Immunostimulants from Microalgae’.

The extract has a strong scientific pedigree, resulting in a patent issued April 17, 2007. United States Patent #US 7,205,284 B2 ‘Potent Immunostimulants from Microalgae’.